Welcome to our dedicated page for Alerian MLP Index ETN SEC filings (Ticker: amjb), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alerian MLP Index ETN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alerian MLP Index ETN's regulatory disclosures and financial reporting.
JPMorgan Chase insider Stacey Friedman has filed a Form 144 indicating an intent to sell 3,404 shares of common stock. The planned sale, through J.P. Morgan Securities LLC on the NYSE, has an aggregate market value of 1,042,985.11 based on the filing.
The shares to be sold were originally acquired on 03/25/2022 as equity compensation awards from the issuer. The filing also notes a prior sale of 3,404 shares of common stock on 01/16/2026, which generated gross proceeds of 1,064,758. Shares outstanding were 2,696,272,576 as of the figures used in the notice.
A shareholder filed a Form 144 notice to sell 3,907 shares of common stock, with an aggregate market value of $1,197,158.15. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE around 02/17/2026. These shares were acquired on 01/13/2022 as equity compensation awards from the issuer. The filer also sold 3,908 shares of the same common stock on 01/16/2026 for gross proceeds of $1,222,353.41, as disclosed for sales during the past three months.
Douglas Petno filed a Form 144 notice to sell 3,487 shares of JPM common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $1,068,428.91. The filing lists 2,696,272,576 shares of common stock outstanding.
The shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer. The notice also reports that during the past three months, Petno sold 3,487 shares of common stock on 01/16/2026 for gross proceeds of $1,090,727.70.
JPM common stock holder Mary Erdoes filed a notice to sell 5,731 shares of common stock, with an aggregate market value of $1,756,045.86, through J.P. Morgan Securities LLC on or about 02/17/2026 on the NYSE. The filing lists 2,696,272,576 common shares outstanding.
The 5,731 shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer. Over the prior three months, Erdoes sold 5,732 shares of the same common stock on 01/16/2026 for gross proceeds of $1,792,878.56.
JPMorgan Chase investor plans a small insider sale. A holder intends to sell 2,047 shares of JPMorgan Chase common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of February 17, 2026 and an aggregate market value of 627,207.13.
The shares were acquired on January 13, 2026 as equity compensation awards from the issuer. The filing also notes that a person named Lori Beer sold 2,047 common shares on January 16, 2026, generating gross proceeds of 640,295.04.
JPMorgan Chase insider plans and reports stock sales. A Form 144 notice covers a proposed sale of 2,892 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $886,156.96, against 2,696,272,576 shares outstanding.
The shares were acquired on January 13, 2026 as equity compensation from the issuer. The filing also notes that Jeremy Barnum sold 2,893 shares of $1 par value common stock on January 16, 2026 for gross proceeds of $904,889.57. The filer represents they are not aware of undisclosed material adverse information.
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering auto callable yield notes linked to the worst performer of Broadcom, Eli Lilly and Micron common stock. The notes pay at least 20.00% per annum, credited monthly, as long as they remain outstanding.
The notes may be automatically called on scheduled review dates starting in August 2026 if each stock is at or above its initial price, returning $1,000 per note plus the applicable interest. If not called, principal repayment at maturity in August 2027 depends on the weakest stock: as long as each final stock price is at least 50.00% of its initial value, investors receive full principal plus the final interest payment.
If any stock finishes below its 50.00% trigger, principal is reduced one-for-one with the decline of the worst stock, and investors can lose more than half, up to all, of their investment. The notes are unsecured obligations subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co. An example estimated value is $962.20 per $1,000 note, and the final estimated value will not be less than $900.00.
JPMorgan Chase Financial Company LLC is offering five-year Trigger GEARS, unsecured notes linked to an unequally weighted basket of six major equity indices: S&P 500 (45%), EURO STOXX 50 (22%), Nikkei 225 (13.75%), FTSE 100 (9.63%), Swiss Market Index (5.50%) and S&P/ASX 200 (4.13%).
The notes are issued at $10 per Security, in $10 increments with a $1,000 minimum, and pay no interest or dividends. At maturity, if the basket has risen, investors receive $10 plus the basket return multiplied by an Upside Gearing between 1.15 and 1.30. If the basket is flat or down but still at or above 75% of its initial basket value, principal is repaid. If the basket falls below that 75% downside threshold, repayment is reduced dollar-for-dollar with the negative basket return, and investors can lose all principal.
The notes are fully and unconditionally guaranteed by JPMorgan Chase & Co., but payments depend on the credit of both issuer and guarantor. The public issue price is $10.00, including up to $0.35 per $10 in selling commissions to UBS, while the indicative estimated value is about $9.48 per $10 (and will not be less than $9.10), reflecting embedded structuring and hedging costs.
JPMorgan Chase & Co. is offering callable floating rate notes linked to a SOFR-based benchmark, scheduled to mature on February 27, 2036. Investors receive principal at maturity plus any accrued interest, provided the notes have not been redeemed early.
The notes pay interest quarterly at a rate equal to the applicable Benchmark Rate plus 1.00%, subject to a minimum interest rate of 3.00% per annum and a maximum interest rate of 6.00% per annum. Interest is calculated using Compounded SOFR (or a benchmark replacement after a benchmark transition event) over defined observation periods and uses a 30/360 day count convention.
JPMorgan may redeem the notes in whole, but not in part, on specified quarterly redemption dates from 2028 through 2035 at par plus accrued interest. The filing highlights risks tied to SOFR’s limited history, potential benchmark transitions, subordination of noteholders in a resolution scenario, and the possibility of limited secondary market liquidity.
JPMorgan Financial is issuing $838,000 of unsecured callable contingent interest notes linked to the worst performer of the S&P 500 Index, the State Street Technology Select Sector SPDR ETF and the VanEck Gold Miners ETF, fully and unconditionally guaranteed by JPMorgan Chase & Co.
The notes pay a monthly contingent coupon at a rate of 13.25% per annum only if on a review date each underlying is at or above 60% of its initial value; otherwise no interest is paid for that period. JPMorgan may redeem the notes early on specified interest payment dates starting May 15, 2026, paying $1,000 plus any due coupon.
If the notes are not called and any underlying finishes below its 60% trigger on the final review date, principal is reduced one-for-one with the decline of the worst-performing underlying, potentially down to zero. The notes priced at $1,000 per unit with an estimated value of $966.70, will not be listed, are subject to JPMorgan’s credit risk and are not FDIC insured.